LONZA GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 526.2 CHF | -0.04% |
|
+1.27% | +48.77% |
| May. 10 | Lonza Group AG Announces Board Changes | CI |
| May. 10 | Lonza Group AG Approves Cash Dividend, Payable on May 15, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 6.66B 7.35B | Sales 2025 * | 7.55B 8.33B | Capitalization | 37.95B 41.85B |
|---|---|---|---|---|---|
| Net income 2024 * | 887M 978M | Net income 2025 * | 1.1B 1.21B | EV / Sales 2024 * | 6.07 x |
| Net Debt 2024 * | 2.48B 2.74B | Net Debt 2025 * | 2.79B 3.08B | EV / Sales 2025 * | 5.4 x |
| P/E ratio 2024 * |
42.8
x | P/E ratio 2025 * |
34.2
x | Employees | 18,000 |
| Yield 2024 * |
0.86% | Yield 2025 * |
0.99% | Free-Float | 95.87% |
More Fundamentals
* Assessed data
More news
Latest transcript on Lonza Group AG
More recommendations
More press releases
More news
| 1 day | -0.04% | ||
| 1 week | +1.27% | ||
| Current month | +3.10% | ||
| 1 month | -1.72% | ||
| 3 months | +17.77% | ||
| 6 months | +57.26% | ||
| Current year | +48.77% |
1 week
516.80
533.40
1 month
497.60547.60
Current year
339.00559.40
1 year
308.60599.40
3 years
308.60785.40
5 years
301.00785.40
10 years
89.30785.40
| Managers | Title | Age | Since |
|---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 17-04-24 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 21-11-30 |
Maria Nunez
COO | Chief Operating Officer | 55 | 22-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 14-04-15 |
| Director/Board Member | 66 | 14-04-15 | |
Marion Helmes
BRD | Director/Board Member | 58 | 22-05-04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.53% | 2 M€ | -.--% | ||
| 3.83% | 121 M€ | -.--% | ||
| 1.77% | 0 M€ | +7.69% | - | |
| 1.74% | 7 M€ | -.--% | - | |
| 0.95% | 0 M€ | +9.46% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 526.2 | -0.04% | 172,626 |
| 24-05-08 | 526.4 | +1.19% | 164,659 |
| 24-05-07 | 520.2 | +0.35% | 115,131 |
| 24-05-06 | 518.4 | -0.23% | 110,459 |
| 24-05-03 | 519.6 | +1.09% | 153,538 |
Delayed Quote Swiss Exchange, May 10, 2024 at 11:31 am EDT
More quotes
Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows:
- bio-pharmaceuticals (52.6%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.;
- capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (20.3%). In addition, the group offers nutritional ingredients;
- small molecule drug substances (13.2%);
- technologies and platforms for manufacturing processes and production of cell and gene therapies (11.1%);
- other (2.8%).
Net sales are distributed geographically as follows: Switzerland (16%), Europe (29.8%), the United States (38.8%), the Americas (3%), Japan (3.7%), China (2.6%), Asia (5.8%) and other (0.3%).
Calendar
2024-05-12
- Ex-dividend day for final dividend
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
526.2
CHF
Average target price
573.9
CHF
Spread / Average Target
+9.06%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +48.77% | 41.85B | |
| +17.96% | 44.96B | |
| +1.17% | 42.65B | |
| -4.27% | 29.04B | |
| +11.42% | 26.08B | |
| -21.39% | 19.03B | |
| +4.86% | 12.75B | |
| +27.29% | 12.06B | |
| -3.50% | 11.75B | |
| +20.18% | 11.72B |
- Stock Market
- Equities
- LONN Stock
